Ileana L. Piña MD, MPH, FAHA, FACC
Quality Officer for the Cardiovascular Line, Thomas Jefferson University/Sidney Kimmel College of Medicine, Philadelphia, Pennsylvania; Clinical Professor, Central Michigan University, Mount Pleasant, MichiganIleana L. Piña, MD, MPH, is Quality Officer for the Cardiovascular Line at Thomas Jefferson University/Sidney Kimmel College of Medicine in Philadelphia, Pennsylvania. She is Clinical Professor at Central Michigan University in Mount Pleasant and is Adjunct Professor of Epidemiology and Biostatistics, Population and Quantitative Health Sciences, at Case Western University, Cleveland, Ohio. Dr. Piña also serves as Senior Fellow and Medical Officer to the Food and Drug Administrations’ Center for Devices and Radiological Health.
Dr. Piña’s research interests include transition of care in heart failure patients and the role of natriuretic peptide–guided management for patients hospitalized for heart failure, biomarkers of myocardial stress and fibrosis in chronic heart failure, and heart failure differences by sex. She has been actively involved in gender, racial, and ethnic issues in healthcare delivery. She is the author/co-author of more than 250 publications.
Disclosures
- Advisory boards: Vifor Pharma (acquired by CSL in 2022), modest; AstraZeneca, modest
Recent Contributions to PracticeUpdate:
- ACC 2023: Recommendations From Dr. Ileana Piña
- Adding the Fourth Pillar of Care Into Practice
- Exercise Training in HFrEF and Permanent Atrial Fibrillation
- 2022 Top Story in Cardiology: Heart Failure With Preserved Systolic Function
- Safety, Tolerability, and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure
- Clinical Guidelines for Heart Failure With Reduced Ejection Fraction (HFrEF)
- GALACTIC-HF Trial: Effects of Omecamtiv Mecarbil in HFrEF
- Review of EMPEROR Trial
- Effect of Dapagliflozin Across the Range of LVEF in Patients With Heart Failure
- ESC 2022: Recommendations From Dr. Ileana Piña